Status:
RECRUITING
The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases
Lead Sponsor:
The University of Hong Kong
Conditions:
Diabetes Mellitus
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Objectives and aim: To evaluate the long-term spill-over (indirect) effect of Coronavirus disease (COVID-19) on health outcomes and healthcare utilization among people with non-communicable diseases a...
Detailed Description
This study aims to evaluate the spill-over impact of the COVID-19 outbreak on health outcomes, healthcare utilization, and costs in patients with major non-communicable diseases (NCDs). The study will...
Eligibility Criteria
Inclusion
- (For cohort study)
- People aged 18 years or above with a documented doctor-diagnosed NCDs (diabetes mellitus, hypertension, cardiovascular disease, cancer, chronic kidney disease, or chronic respiratory disease )
- People who attended at least once HA hospitals, general or specialist out-patients clinics between 1 January 2010 and 31 December 2024
Exclusion
- \- People with a documented doctor-diagnosed COVID-19
- (For cross-sectional study)
- Inclusion Criteria:
- People aged 18 years or above with a documented doctor-diagnosed NCDs (diabetes mellitus, hypertension, cardiovascular disease, cancer, chronic kidney disease, or chronic respiratory disease )
- All participants are able to communicate in either Chinese or English and provide informed consent.
Key Trial Info
Start Date :
June 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
250000 Patients enrolled
Trial Details
Trial ID
NCT05248412
Start Date
June 21 2021
End Date
June 30 2026
Last Update
March 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Family Medicine & Primary Care, LKS Faculty of Medicine, University of Hong Kong
Hong Kong, Hong Kong, China